Imaging used to inspect Eiffel Tower art

Share this on social media:

An imaging software program, written in LabView from National Instruments, has been used to inspect lighting patterns on a contemporary art installation, made by Développement Ingénierie (DI) in partnership with the City of Paris and the operating company of the Eiffel Tower.

The company has created a collection of 12 unique pieces that are made ​​from beams and decorative original arches of the Eiffel Tower structure and include a clock showing the stylised Eiffel Tower and Paris. These replicas show the exact same time as the Eiffel Tower through an onboard GPS receiver.

LabView software was used to program the inspection of a series of LEDs and lamps decorating the installation, which are illuminated in both progressive and random changing patterns. The software program was used to check an image obtained of the lights after each change was in accordance with the illumination algorithm used.

Digits from zero to nine show the number of years and days since the inauguration of the Eiffel Tower are also on the installation. The system automatically extracts the digits from a framed image and analyses the correlation with previously stored 2D reference images. This technique provided a 2D correlation recognition rate of 100 per cent of digits.

Recent News

12 February 2021

Video recorded at 2,800 frames per second has been used to test high-speed trains travelling through the newly opened Ceneri Base Tunnel in Switzerland

29 July 2020

The Perseverance rover contains 19 cameras, including seven scientific instruments. It will analyse the climate and geology of Mars, looking for signs of past life, as well as monitoring the Martian atmosphere

02 July 2020

Norwegian seafood firm, Lerøy, has installed hyperspectral cameras on processing lines to sort fish. The system is able to measure the amount of blood in white fish, which gives a grade of quality

09 June 2020

Hyperspectral imaging is being used in a research programme at hospitals in Maryland and New York to investigate the prognostic value of skin findings associated with Covid-19 infection